1-(4-(4-Chlorophenyl)-3-phenylbut-2-en-1-yl)pyrrolidine

Catalog No. :
ACWGNT579
CAS No. :
91-82-7
Molecular Formula :
C20H22ClN
Molecular Weight :
311.86

IUPAC Name:(Z)-1-(4-(4-chlorophenyl)-3-phenylbut-2-en-1-yl)pyrrolidine

1-(4-(4-Chlorophenyl)-3-phenylbut-2-en-1-yl)pyrrolidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(4-Chlorophenyl)-3-phenylbut-2-en-1-yl)pyrrolidine
IUPAC Name(Z)-1-(4-(4-chlorophenyl)-3-phenylbut-2-en-1-yl)pyrrolidine
Molecular FormulaC20H22ClN
Molecular Weight311.86
SMILESClC1=CC=C(C/C(C2=CC=CC=C2)=C/CN3CCCC3)C=C1
InChI KeyWDYYVNNRTDZKAZ-UNOMPAQXSA-N
Synonym1-(4-(4-chlorophenyl)-3-phenylbut-2-enyl)pyrrolidine;1-[3-(4-Chlorobenzyl)-3-phenyl-2-propenyl]pyrrolidine;1-[4-(4-Chlorophenyl)-3-phenyl-2-butenyl]pyrrolidine;Pyronil;1-[4-(4-Chlorophenyl)-3-phenyl-2-buten-1-yl]pyrrolidine;1-[γ-(p-Chlorobenzyl)cinnaMyl]pyrrolidine;Pyrrobutamine;1-[(E)-4-(4-chlorophenyl)-3-phenylbut-2-enyl]pyrrolidine
CAS No.91-82-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWGNT579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWGNT579 route product structure diagram
    ACWGNT57991-82-7
Inquiry

2. ACWGNT579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWGNT579 route product structure diagram
    ACWGNT57991-82-7
Inquiry

Comments (0)